These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 22237625)
21. A novel function of HPV16-E6/E7 in epithelial-mesenchymal transition. Jung YS; Kato I; Kim HR Biochem Biophys Res Commun; 2013 Jun; 435(3):339-44. PubMed ID: 23628416 [TBL] [Abstract][Full Text] [Related]
22. Loss of Dependence on Continued Expression of the Human Papillomavirus 16 E7 Oncogene in Cervical Cancers and Precancerous Lesions Arising in Fanconi Anemia Pathway-Deficient Mice. Park S; Park JW; Pitot HC; Lambert PF mBio; 2016 May; 7(3):. PubMed ID: 27190216 [TBL] [Abstract][Full Text] [Related]
23. Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in patients with head-and-neck squamous-cell carcinoma. Zumbach K; Hoffmann M; Kahn T; Bosch F; Gottschlich S; Görögh T; Rudert H; Pawlita M Int J Cancer; 2000 Mar; 85(6):815-8. PubMed ID: 10709102 [TBL] [Abstract][Full Text] [Related]
24. Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention against head and neck cancer-containing HPV16 cell lines. Adhim Z; Otsuki N; Kitamoto J; Morishita N; Kawabata M; Shirakawa T; Nibu K Acta Otolaryngol; 2013 Jul; 133(7):761-71. PubMed ID: 23638950 [TBL] [Abstract][Full Text] [Related]
25. Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene. Herber R; Liem A; Pitot H; Lambert PF J Virol; 1996 Mar; 70(3):1873-81. PubMed ID: 8627712 [TBL] [Abstract][Full Text] [Related]
26. SLC7A11 as a biomarker and therapeutic target in HPV-positive head and neck Squamous Cell Carcinoma. Hémon A; Louandre C; Lailler C; Godin C; Bottelin M; Morel V; François C; Galmiche A; Saidak Z Biochem Biophys Res Commun; 2020 Dec; 533(4):1083-1087. PubMed ID: 33019976 [TBL] [Abstract][Full Text] [Related]
27. Differential anticancer activities of arsenic trioxide on head and neck cancer cells with different human papillomavirus status. Du S; Liu K; Gao P; Li Z; Zheng J Life Sci; 2018 Nov; 212():182-193. PubMed ID: 30243648 [TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus type 16 in head and neck carcinogenesis. Chen R; Aaltonen LM; Vaheri A Rev Med Virol; 2005; 15(6):351-63. PubMed ID: 15942978 [TBL] [Abstract][Full Text] [Related]
29. Human papillomavirus type 16 E6 and E7 genotypes in head-and-neck carcinomas. Hoffmann M; Lohrey C; Hunziker A; Kahn T; Schwarz E Oral Oncol; 2004 May; 40(5):520-4. PubMed ID: 15006625 [TBL] [Abstract][Full Text] [Related]
30. Biological basis for increased sensitivity to radiation therapy in HPV-positive head and neck cancers. Bol V; Grégoire V Biomed Res Int; 2014; 2014():696028. PubMed ID: 24804233 [TBL] [Abstract][Full Text] [Related]
31. Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus. Smeets SJ; Braakhuis BJ; Abbas S; Snijders PJ; Ylstra B; van de Wiel MA; Meijer GA; Leemans CR; Brakenhoff RH Oncogene; 2006 Apr; 25(17):2558-64. PubMed ID: 16314836 [TBL] [Abstract][Full Text] [Related]
32. Detection of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma using droplet digital polymerase chain reaction. Biron VL; Kostiuk M; Isaac A; Puttagunta L; O'Connell DA; Harris J; Côté DW; Seikaly H Cancer; 2016 May; 122(10):1544-51. PubMed ID: 26989832 [TBL] [Abstract][Full Text] [Related]
33. HPV16 E6 and E7 proteins induce a chronic oxidative stress response via NOX2 that causes genomic instability and increased susceptibility to DNA damage in head and neck cancer cells. Marullo R; Werner E; Zhang H; Chen GZ; Shin DM; Doetsch PW Carcinogenesis; 2015 Nov; 36(11):1397-406. PubMed ID: 26354779 [TBL] [Abstract][Full Text] [Related]
34. The relative ability of human papillomavirus type 6 and human papillomavirus type 16 E7 proteins to transactivate E2F-responsive elements is promoter- and cell-dependent. Armstrong DJ; Roman A Virology; 1997 Dec; 239(1):238-46. PubMed ID: 9426463 [TBL] [Abstract][Full Text] [Related]
35. Identifying predictors of HPV-related head and neck squamous cell carcinoma progression and survival through patient-derived models. Facompre ND; Rajagopalan P; Sahu V; Pearson AT; Montone KT; James CD; Gleber-Netto FO; Weinstein GS; Jalaly J; Lin A; Rustgi AK; Nakagawa H; Califano JA; Pickering CR; White EA; Windle BE; Morgan IM; Cohen RB; Gimotty PA; Basu D Int J Cancer; 2020 Dec; 147(11):3236-3249. PubMed ID: 32478869 [TBL] [Abstract][Full Text] [Related]
36. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma. Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222 [TBL] [Abstract][Full Text] [Related]
37. Low- and high-risk human papillomavirus E7 proteins regulate p130 differently. Barrow-Laing L; Chen W; Roman A Virology; 2010 May; 400(2):233-9. PubMed ID: 20189212 [TBL] [Abstract][Full Text] [Related]
38. High expression of NFX1-123 in HPV positive head and neck squamous cell carcinomas. Chintala S; Quist KM; Gonzalez-DeWhitt PA; Katzenellenbogen RA Head Neck; 2022 Jan; 44(1):177-188. PubMed ID: 34693597 [TBL] [Abstract][Full Text] [Related]
39. Biomarkers of HPV in head and neck squamous cell carcinoma. Liang C; Marsit CJ; McClean MD; Nelson HH; Christensen BC; Haddad RI; Clark JR; Wein RO; Grillone GA; Houseman EA; Halec G; Waterboer T; Pawlita M; Krane JF; Kelsey KT Cancer Res; 2012 Oct; 72(19):5004-13. PubMed ID: 22991304 [TBL] [Abstract][Full Text] [Related]
40. Estrogen Attenuates the Growth of Human Papillomavirus-Positive Epithelial Cells. Bristol ML; James CD; Wang X; Fontan CT; Morgan IM mSphere; 2020 Mar; 5(2):. PubMed ID: 32188745 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]